Dexcom (DXCM) Share-based Compensation Growth (1y) (2011 - 2026)
Powered by 
Analysis
Dexcom (DXCM) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.00 Bn | 178.39 Bn | 7.27 Bn | 18.31% |
| 2 | Intuitive Surgical | 124.54 Bn | 119.33 Bn | 1.96 Bn | 314.20% |
| 3 | Medtronic | 118.37 Bn | 109.55 Bn | 6.34 Bn | 45.35% |
| 4 | Stryker | 105.22 Bn | 101.74 Bn | 4.50 Bn | -78.13% |
| 5 | Boston Scientific | 66.67 Bn | 66.13 Bn | 3.85 Bn | -15.28% |
| 6 | Edwards Lifesciences | 49.77 Bn | 45.52 Bn | 1.35 Bn | 12.53% |
| 7 | Alcon | 33.91 Bn | 32.45 Bn | 1.68 Bn | 10.53% |
| 8 | Dexcom | 32.34 Bn | 30.39 Bn | 830.00 Mn | -13.91% |
| 9 | Steris | 21.11 Bn | 20.63 Bn | 684.20 Mn | 7.56% |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 9.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.91% |
| Mar 31, 2026 | 26.61% |
| Dec 31, 2025 | -19.17% |
| Sep 30, 2025 | 3.92% |
| Jun 30, 2025 | 1.34% |
| Mar 31, 2025 | -12.31% |
| Dec 31, 2024 | 17.34% |
| Sep 30, 2024 | 11.28% |
| Jun 30, 2024 | 12.59% |
| Mar 31, 2024 | 10.80% |
| Dec 31, 2023 | 8.53% |
| Sep 30, 2023 | 26.62% |
| Jun 30, 2023 | 21.78% |
| Mar 31, 2023 | 20.96% |
| Dec 31, 2022 | 29.28% |
| Sep 30, 2022 | 12.00% |
| Jun 30, 2022 | 3.16% |
| Mar 31, 2022 | 3.93% |
| Dec 31, 2021 | -22.87% |
| Sep 30, 2021 | -10.42% |